483
Konrad Rejdak, M.D.FDA 483 - Konrad Rejdak, M.D. - May 19, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Konrad Rejdak, M.D., a clinical investigator in Lublin, Poland, revealed a significant issue regarding the maintenance of adequate and accurate case histories. The firm failed to ensure source data was available for several subjects' adjusted data, which was not directly recorded as required by their study protocol. This indicates a deficiency in data integrity and record-keeping practices during a clinical investigation.
Open in Dashboard
ID · 0621bedd-73a9-4bbf-a807-86b6efba69a9